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Abstract
Background: Much of the epidemiologic research on risk factors for fibroids, the leading indication for hyster-
ectomy, relies on self-reported outcome. Self-report is subject to misclassification because many women with
fibroids are undiagnosed. The purpose of this analysis was to quantify the extent of misclassification and identify
associated factors.
Methods: Self-reported fibroid status was compared to ultrasound screening from 2046 women in Right From
The Start (RFTS) and 869 women in the Uterine Fibroid Study (UFS). Log-binomial regression was used to
estimate sensitivity (Se) and specificity (Sp) and examine differences by ethnicity, age, education, body mass
index, parity, and miscarriage history.
Results: Overall sensitivity was £ 0.50. Sensitivity was higher in blacks than whites (RFTS: 0.34 vs. 0.23; UFS:
0.58 vs. 0.32) and increased with age. Parous women had higher sensitivity than nulliparae, especially in RFTS
whites (Se ratio = 2.90; 95% confidence interval [CI]: 1.51, 5.60). Specificity was 0.98 in RFTS and 0.86 in UFS.
Modest ethnic differences were seen in UFS (Sp ratio, black vs. white = 0.90; 95% CI: 0.81, 0.99). Parity was
inversely associated with specificity, especially among UFS black women (Sp ratio = 0.84; 95% CI: 0.73, 0.97).
Among women who reported a previous diagnosis, a shorter time interval between diagnosis and ultrasound
was associated with increased agreement between the two measures.
Conclusions: Misclassification of fibroid status can differ by factors of etiologic interest. These findings are useful
for assessing (and correcting) bias in studies using self-reported clinical diagnosis as the outcome measure.
Introduction
Uterine leiomyomata (fibroids) are benign neoplasmsof uterine smooth muscle tissue that develop in the ma-
jority of reproductive-age women.1 For some women, fibroids
can cause menstrual abnormalities, pelvic pain, and pregnancy
complications2 severe enough to require surgical treatment.
However, many women with fibroids remain asymptomatic
throughout their reproductive years. An estimated 20% to 50%
of women with fibroids will experience related symptoms,3,4
and these women will be more likely to be diagnosed.
The large proportion of women with subclinical fibroids
leads to an important methodological challenge for epidemi-
ologic studies. As with any condition with a long preclinical
phase, any ascertainment method that does not attempt to
identify asymptomatic women will misclassify a proportion of
true cases as noncases. This misclassification can be extensive
when outcome ascertainment is obtained by self-report. In the
Uterine Fibroid Study (UFS), 51% of premenopausal women
who reported no previous diagnosis had fibroids upon ultra-
sound examination.1
Incidental detection also affects which women will be
clinically diagnosed. Women who are not experiencing
fibroid-related symptoms could be diagnosed during a rou-
tine pelvic exam or obstetric ultrasound or if seeking care
for other gynecologic conditions. The use of self-report could
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therefore result in spurious associations with factors not re-
lated to uterine fibroids, reflecting instead an underlying
difference in the opportunity for diagnosis. In a large pro-
spective cohort study (Black Women’s Health Study) that
validated positive self-report among a subsample of women,
55% of cases reported being diagnosed because of fibroid-
related symptoms; the remaining 45% were diagnosed inci-
dentally, either during a routine pelvic examination (32%) or
while receiving care for another condition (13%).5
The purpose of this analysis is to evaluate the validity of
self-reported fibroid status and examine possible predictors of
reporting quality. It is well-established that fibroid prevalence
increases with age and that black women are at higher risk
than white women at all ages.6,7 We therefore used data from
two studies with a relatively high proportion of black par-




Data for this analysis came from two studies in which
participants were systematically screened for uterine fibroids
using ultrasound. Right From The Start (RFTS) is an ongoing
community-based prospective study of early pregnancy
conducted since 2000. Women (at least 18 years old) very early
in pregnancy or those planning to become pregnant were
recruited from the community and clinical care sites via out-
reach materials and advertisements. Details of methods and
study design are described elsewhere.8,9 Questionnaire data
were gathered through computer-assisted telephone inter-
view; information on basic demographics was obtained at
enrollment, and questions about medical and reproductive
history were asked in a first trimester interview. Weight and
height were collected at enrollment and during the first tri-
mester ultrasound.
This analysis is limited to women joining RFTS from 2004
onward, when a question on previous fibroid diagnosis was
added to the enrollment interview. Although women were
allowed to re-enroll in the study, we only included records
from the first time they were asked about previous fibroid
diagnoses. Study enrollment was required before 9 completed
weeks of gestation. A total of 2411 women enrolled between
2004 and 2008, and 2341 (97%) had both ultrasound and self-
report information. We included only women whose self-
reported race/ethnicity was non-Hispanic white (n = 1756) or
non-Hispanic black (n = 290) in this analysis.
The UFS was a cross-sectional study conducted between
1996 and 1999 to estimate uterine fibroid prevalence among
35- to 49-year-old women randomly selected from among
members of an urban health plan. Details have been described
previously.1 Approximately 88% of the original random
sample was contacted by telephone and screened for eligi-
bility and 1430 (80%) of the eligible women participated. In-
formation on demographic characteristics and reproductive
and medical history were collected from telephone interviews
and self-administered questionnaires. Height and weight
were measured at the clinic visit. We excluded 107 women
whose reported ethnicity was other than non-Hispanic black
or white, 180 postmenopausal women, 152 missing ultra-
sound, and four with indeterminate ultrasound results. An
additional 118 who had a study ultrasound showing a diffuse
heterogeneous pattern suggestive of fibroids, but no focal fi-
broids were excluded1 because medical practitioners may
vary in whether or not they will tell such patients that they
have fibroids. The final analysis subset included 363 white
and 506 black women.
Self-report of uterine leiomyomata
Both RFTS and the UFS collected information on fibroid
diagnosis by telephone interview prior to conducting the
study ultrasound. Self-reported fibroid status (yes/no) was
based on women’s responses to whether a doctor or medical
care provider had ever told them they had uterine fibroids.
The UFS interview also included a series of follow-up ques-
tions (e.g., diagnostic and follow-up examinations, treat-
ment). Fewer than 10 women who responded ‘‘yes’’ to the
initial question subsequently indicated that the diagnosis
had been incorrect and were classified as having no previous
fibroid diagnosis.
Ultrasound detection of uterine leiomyomata
RFTS participants underwent an endovaginal ultrasound
as early as 6 weeks of gestation and no later than 13 weeks.
Premenopausal participants in the UFS underwent transva-
ginal (and, if necessary for better imaging, transabdominal)
ultrasound examinations within 3 months of study entry. In
both studies, examinations were performed by sonographers
certified by the American Registry of Diagnostic Medical So-
nographers who received additional study training for con-
sistency in identifying, measuring, and recording uterine
fibroids.1,8 RFTS sonographers had three or more years of
clinical obstetric-gynecologic experience. UFS examinations
were performed by gynecologic sonographers under the di-
rect supervision of a radiologist with fellowship training in
ultrasonography. In both studies, any questionable sono-
grams were examined by study physicians. Sonographers
were instructed not to discuss prior knowledge of fibroid
status with study participants.
Recorded measurements included the number, location,
and size of each tumor. The diameter of each tumor was
measured in three perpendicular planes. Because RFTS par-
ticipants were pregnant, each tumor was measured three
times during the exam (with intervening time between mea-
surements) to reduce the chance of misidentifying focal con-
tractions as fibroids, and the mean of these diameter
measurements was calculated for each tumor.8 In the UFS, 170
women who had had a recent pelvic ultrasound were classi-
fied as positive or negative for fibroids based on their radi-
ology records.
Fibroid identification was based on the Muram criteria10 of a
mass that is relatively spherical and echogenically different from
the surrounding myometrium, but the size criterion was modi-
fied to include masses of ‡ 0.5 cm. Women were classified as
having uterine fibroids if the results of the ultrasound exami-
nation indicated presence of one or more fibroids. Fibroid size
was categorized as < 2.00, 2.00–3.99, and ‡ 4.00 cm based on the
largest measured diameter for the tumor(s) detected. A total of
23 (3%) UFS and 16 (1%) RFTS participants reported having
previous surgery to remove fibroids. For this analysis, these
women were classified as having fibroids, even if the study ul-
trasound did not show evidence of tumors. We assigned fibroid
size as ‡ 4.00 cm for women who had fibroid surgery.
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Data analysis
The validity of self-reported uterine fibroid status as com-
pared to the ultrasound examination was measured by sen-
sitivity and specificity. Sensitivity was defined as the
proportion of women who self-reported a previous fibroid
diagnosis among those with ultrasound-confirmed fibroids or
prior fibroid surgery. Specificity was defined as the propor-
tion of women who self-reported no previous diagnosis
among those with no evidence of fibroids at ultrasound and
no previous fibroid surgery. RFTS and UFS data were ana-
lyzed separately due to differences in the study populations.
All analyses were carried out with the statistical software
package SAS 9.1 (SAS Institute Inc.). Log-binomial regression
was used to estimate sensitivity and specificity with 95%
confidence intervals (CIs). Prevalence ratios obtained from the
regression models are interpreted in this analysis as the sen-
sitivity (or specificity) of self-report in one subgroup com-
pared to that in a reference group. These ratio measures were
used to examine differences in self-report validity according
to age at interview, education, body mass index (BMI), parity,
miscarriage history, and (for sensitivity only) size of the
largest fibroid detected at ultrasound.
Univariate analyses were conducted to assess the associa-
tion of each individual predictor with sensitivity and speci-
ficity, respectively. Statistical interaction by ethnicity and age
was tested using the Mantel-Haenszel v2 test for homogeneity
with a p < 0.10 significance level. Ethnicity modified the as-
sociation between sensitivity and parity in RFTS ( p = 0.06),
and sensitivity and fibroid size in UFS ( p < 0.05). Both overall
and ethnicity-stratified estimates are presented here.
Adjusted models included covariates that were associated
( p < 0.10) with sensitivity (or specificity) in the univariate
analyses. Sensitivity ratios were adjusted for parity (any
previous birth vs. none) and age as a continuous variable
(with a quadratic term in the UFS analysis to accommodate
nonlinearity). UFS specificity ratios were adjusted for parity,
but no adjustment was made in RFTS due to the small number
of women who did not have ultrasound-detected fibroids but
reported a previous diagnosis. Linearity of trends for cate-
gorical predictors was examined by treating categorical var-
iables as ordinal parameters in the models. Poisson regression
with robust error variance was used when log-binomial
models did not converge.11
Results
Overall, RFTS participants were about 10 years younger
than UFS participants (Table 1). On average, black women
were 2.8 years younger than white women in RFTS. Black and
white women differed with respect to education, BMI, and
parity in both study populations. Prevalence of both self-
reported and ultrasound-detected fibroids was higher among
black women compared to whites in both study populations,
but lower in both groups in RFTS compared to UFS. Fur-
thermore, a higher percentage of black than white women had
fibroids ‡ 4 cm in diameter. Among those who had a previous
diagnosis in the UFS, the reported age at first diagnosis was
3 years younger in black compared to white women.
Sensitivity (Se) was low among participants of both studies
(Supplementary Table S1; Supplementary Data are available
online at www.liebertonline.com/jwh). Half of the UFS par-
ticipants who had fibroids at study ultrasound reported a
previous diagnosis (Se: 0.50; 95% CI: 0.45, 0.54). Sensitivity
was even lower (Se: 0.27; 95% CI: 0.22, 0.32) in RFTS. As
shown in Figs. 1 and 2, black women had higher sensitivity of
self-report than did white women; this was more pronounced
in the UFS participants (sensitivity ratio [SeR]: 1.73; 95% CI:
1.33, 2.25). Sensitivity was associated with age at interview
in both studies (Figs. 1 and 2). In RFTS, overall sensitivity
increased from 0.12 (95% CI: 0.07, 0.21) in 18- to 29-year-
old women to 0.41 (95% CI: 0.31, 0.53) in 35- to 45-year-olds
( p for trend < 0.005). Among UFS participants, sensitivity was
higher among black women in their 40s compared to 35- to 39-
year-olds, but there were no significant differences by age for
white women.
Figure 2 provides sensitivity ratios for additional demo-
graphic and reproductive factors. Parity was associated with
higher sensitivity of self-report among white women, with
the strongest association seen in white RFTS participants
(SeR: 2.90; 95% CI: 1.51, 5.60). Among black women, those
with postbaccalaureate education had somewhat higher self-
report sensitivity than those with less than 4 years of college,
but this difference was statistically significant only in the
UFS (SeR: 1.27; 95% CI: 1.05, 1.55). Neither BMI nor mis-
carriage history was a predictor of self-report sensitivity in
either study population.
In both studies, women with larger fibroids at the ultra-
sound examination had significantly higher sensitivity of self-
report (Table 2). After adjusting for age and parity, sensitivity
was three to four times as high in women with tumors ‡ 4 cm
as in those whose largest tumor was < 2 cm in diameter. The
exception was among UFS black women for whom the ad-
justed association with fibroid size was not as strong (SeR for
‡ 4 vs. < 2 cm: 1.88; 95% CI: 1.42, 2.49), despite the women with
large fibroids in this group having the highest sensitivity (0.79).
Specificity (Sp)—the proportion of women reporting ‘‘no
fibroid diagnosis’’ among those with no ultrasound-detected
fibroids—was high in both study populations. In RFTS,
overall specificity was 0.98 (95% CI: 0.97, 0.99) compared with
0.86 (95% CI: 0.82, 0.90) in the UFS (Supplementary Table S2).
Unlike the sensitivity results, there were few differences in
specificity of self-report among the factors considered (Fig. 3).
In RFTS, specificity was almost equal between blacks and
whites (0.98 and 0.97, respectively). However, specificity for
black women in the UFS was lower compared to whites
(specificity ratio: 0.90; 95% CI: 0.81, 0.99). As shown in Fig. 1,
age at interview was inversely associated with specificity in
RFTS ( p for trend < 0.01) but not significantly in the UFS ( p for
trend = 0.15). In both study populations, parous women had
lower specificity compared to nulliparae, and this was seen
among both blacks and whites (Fig. 3). Specificity was unre-
lated to education, BMI, or miscarriage history.
Overall agreement between self-report and ultrasound fi-
broid status was 88% in RFTS and 65% in the UFS (data not
shown). The combination of differences in sensitivity, speci-
ficity, and prevalence of ultrasound-detected fibroids by race
and age yielded the highest agreement (93%) in the youngest
(ages 18–29 years) white women, and the lowest agreement
(47%) in the oldest white women (ages 45–49 years). Among
black women, agreement between self-report and ultrasound
fibroid status was also highest in the youngest age group and
varied from 83% to 60%.
We examined factors since diagnosis—time interval, age at
ultrasound, intervening pregnancy—among UFS women
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Table 1. Characteristics of Right From The Start (n = 2046)
and Uterine Fibroid Study (n = 869) Analysis Populations, by Race/Ethnicity
RFTS UFS
White (n = 1756) Black (n = 290) White (n = 363) Black (n = 506)
No. % No. % No. % No. %
Age at interview
< 20 18 1.0 22 7.6 0 0
20–24 134 7.6 80 27.6 0 0
25–29 658 37.5 76 26.2 0 0
30–34 629 35.8 85 29.3 0 0
35–39 279 15.9 22 7.6 124 34.2 191 37.7
40–44 38 2.2 5 1.7 122 33.6 178 35.2
45–49 0 0 117 32.2 137 27.1
Mean (SD)a 30.2 (4.5) 27.4 (5.6) 41.9 (4.3) 41.4 (4.2)
Highest educationb
High school 124 7.1 74 25.5 12 3.4 104 20.9
Some college 229 13.0 95 32.8 33 9.3 228 45.8
4 years of college 665 37.9 71 24.5 54 15.3 66 13.3
Postbaccalaureate 737 42.0 50 17.2 254 72.0 100 20.1
Missing 1 0 10 8
BMI (kg/m2) at enrollmentc
< 20.00 186 10.6 18 6.2 27 7.4 16 3.2
20.00–24.99 945 53.8 75 25.9 183 50.4 117 23.2
25.00–29.99 374 21.3 78 26.9 91 25.1 155 30.7
‡ 30.00 251 14.3 119 41.0 62 17.1 217 43.0
Missing 0 0 0 1
Parity
0 803 48.3 118 45.2 219 60.3 115 22.7
1 608 36.6 93 35.6 52 14.3 120 23.7
2 198 11.9 35 13.4 75 20.7 159 31.4
3 or more 54 3.2 15 5.7 17 4.7 112 22.1
Missing 93 29 0 0
No. of miscarriagesd
0 669 65.4 120 62.2 147 69.7 317 69.7
1 277 27.1 57 29.5 47 22.3 112 24.6
2 or more 77 7.5 16 8.3 17 8.1 26 5.7
Missing 64 20 0 0
Previous fibroid diagnosis (self-report)
No 1,680 95.7 255 87.9 294 81.0 271 53.6
Yes 76 4.3 35 12.1 69 19.0 235 46.4
Mean (SD) age at diagnosis 29.3 (5.2) 28.4 (4.0) 36.2 (5.6) 33.0 (7.2)
Missing age at diagnosis 15 7 4 14
Ultrasound-detected fibroids
No 1,560 88.8 207 71.4 201 55.4 161 31.8
Yes, size of largest tumor 196 11.2 83 28.6 162 44.6 345 68.2
< 2.00 cm 96 49.0 38 45.8 62 38.3 78 22.6
2.00–3.99 cm 62 31.6 19 22.9 60 37.0 140 40.6
‡ 4.00 cm 38 19.4 26 31.3 40 24.7 127 36.8
Mean (SD) age of first
diagnosise
31.1 (5.1) 29.1 (4.7) 40.9 (5.9) 36.3 (7.5)
Missing 15 7 4 14
aSD, standard deviation.
bRFTS asked for years of schooling completed and was categorized as follows: £ 12, high school; 13–15, some college; 16, 4 years of college;
and > 16, postbaccalaureate. The high school category includes some women with less than a high school education: 11 black UFS women,
and 19 white and 21 black RFTS women. The postbaccalaureate category includes 197 white and 11 black women in the UFS who reported
having a graduate/professional degree.
cFor RFTS, BMI was based on self-reported prepregnancy height and weight or first trimester clinic measures when missing.
dAmong 1087 white and 213 black RFTS women with a previous pregnancy (prior to study enrollment); 211 white and 455 black UFS
women with a previous pregnancy.
eAmong all women with fibroids previously diagnosed or newly detected at ultrasound.
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with positive self-report to investigate what might account for
their lower specificity (data not shown). Only the UFS black
women were examined (n = 221) because there were few UFS
white women reporting a previous diagnosis who did not
have ultrasound-detected fibroids. A short time interval be-
tween prior diagnosis and study ultrasound was associated
with increased concordance between self-report and ultra-
sound. Concordance was highest (90.4%) among women who
reported a diagnosis within 2 years of the study ultrasound.
Excluding women whose reported age at diagnosis was more
than 2 years before the ultrasound increased the overall
specificity of self-report from 0.86 to 0.98 and eliminated
specificity differences by ethnicity, age, and parity. Age at
ultrasound was also important, even after controlling for
years since diagnosis. Concordance was 23% higher for wo-
men 40 years or older relative to that for women 35–39 years
old at the time of the ultrasound examination.
Discussion
Much of the published data on risk factors for fibroids is
based on self-reported fibroid status.6 To our knowledge, this
is the first detailed assessment of the sensitivity and specificity
of this outcome measure. Our results quantify what is gen-
erally accepted as a limitation of these data, namely the mis-
classification of women with (undiagnosed) fibroids as
noncases. Overall sensitivity of self-report was quite low: 0.27
in RFTS and 0.50 in the UFS. In addition, results provide ev-
idence that this misclassification can occur differentially with
respect to certain factors.
Sensitivity of self-report tended to increase with age and
was higher in black women compared with white women.
Black women generally have a younger age at onset and lar-
ger and more numerous tumors compared with similarly
aged whites.6,12,13 Higher self-report sensitivity could occur if
these differences lead to more severe symptoms or easier
detection during routine pelvic examination or if there is in-
creased gynecologic surveillance of black women as a ‘‘high-
risk’’ group. Ethnic differences in tumor onset and growth
may also explain the apparent drop in sensitivity noted in the
oldest white women. Among 45- to 49-year-old white women
with fibroids, the proportion with large tumors was lower
compared to 35- to 44-year-olds (0.22 vs. 0.28, respectively),
while the proportion of black women with large tumors in-
creased with age. This may reflect a difference in the natural
progression of these tumors, such that fibroids that first de-
velop in white women in their 40’s remain small enough to go
undetected. In a study that tracked fibroid growth in tumors
from 72 premenopausal women, older white women had a
lower growth rate than their younger counterparts, while this
age difference was not seen in black women.14
Parity was associated with higher self-report sensitivity
among white women, which may reflect possible ethnic dif-
ferences in prenatal care and an increased opportunity for
diagnosis through pregnancy-related ultrasound examina-
tions. However, we did not find a further association with
miscarriage history, which could have increased gynecologic
surveillance.
In contrast to the low sensitivity values, specificity was
relatively high: 0.98 in RFTS and 0.86 in UFS. Associations
with age, ethnicity, and parity were in the opposite direction
as the sensitivity results, but relatively weak overall. The
principal limitation in interpreting the specificity results lies in
the possibility that women who reported having been previ-
ously diagnosed could have reported accurately, but fibroid
regression after prior diagnosis resulted in no detectable fi-
broids at subsequent screening ultrasound. Our finding that
the proportion of apparent false-positives increased with
duration between first diagnosis and ultrasound suggests that
specificity may be affected by time since diagnosis as well as
age at interview. We demonstrated that limiting the specific-
ity analysis to women who were more recently diagnosed
increased specificity in the UFS to levels close to those seen in
RFTS. The few studies that have tracked fibroid growth have
found a wide variation in growth rates, but spontaneous re-
gression was seen in only a small proportion of tumors.14–16
FIG. 1. Self-report sensitivity (upper panel) and specificity
(lower panel) by race/ethnicity and age at interview for
Right From The Start (RFTS, n = 2046) and Uterine Fibroid
Study (UFS, n = 869) participants. Error bars indicate 95%
confidence intervals (CI). Estimates for the following RFTS
age groups are excluded because there were fewer than 10
women in each race/age category: sensitivity for women
aged 18–24 years and black women over 40 years; specificity
for black women aged 40–44 years.
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Specificity could also be lower in women who have inter-
vening pregnancies because pregnancy-associated factors
have been shown to reduce or eliminate fibroids.17,18 On the
other hand, self-report of previous diagnosis may have been
in error. Two prospective cohorts have examined self-report
accuracy in validation subsamples and were unable to con-
firm fibroid diagnosis in 4%–8% of women reporting a diag-
nosis for whom medical records were obtained.5,13 We did not
have access to complete medical record history to review the
validity of earlier diagnoses.
A strength of this analysis was the large sample size,
which allowed us to examine both black and white women
over a large age range. However, generalizability of our
findings to other groups must be considered. Women in
RFTS volunteered for the study, and most had planned
pregnancies. Compared to the general population, they were
more highly educated, less likely to smoke, and more likely
to be married.8 They had achieved the index pregnancy
without fertility treatment, so women with fertility problems
(possibly due to uterine fibroids) are underrepresented.
RFTS was described in recruitment materials as a study of
early pregnancy health and not specifically as a study
of uterine fibroids, so it is unlikely that participants vo-
lunteered because of their concern about fibroids. UFS par-
ticipants were members of a health plan and therefore had
access to health-care services. Self-report from women with
limited access to or use of health care might show lower
sensitivity than our results. However, the fact that we ob-
served similar results in these two different study popula-
tions lends support to our findings.
FIG. 2. Association of demographic and reproductive factors with sensitivity of self-reported uterine fibroid status among
279 RFTS and 507 UFS participants with fibroids detected at study ultrasound. Sensitivity ratios (sensitivity in a subgroup of
interest compared to sensitivity in the reference group) are adjusted for age (continuous), parity, and (for unstratified
estimates) race/ethnicity. A quadratic term was entered for age in the UFS multivariate analysis due to nonlinearity. aAmong
women with a previous pregnancy. bEstimates obtained using Poisson regression.
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Table 2. Relationship Between Size of Largest Fibroid Detected at Study Ultrasound
and Sensitivity of Self-Report in 279 Right From The Start and 507 Uterine Fibroid Study
Participants With Fibroids Detected at Study Ultrasound




correct Total Se 95% CI SeRa 95% CI
No.
correct Total Se 95% CI SeRa 95% CI
RFTS, cm
< 2.00 14 96 0.15 0.09, 0.24 1.00 Referent 5 38 0.13 0.06, 0.30 1.00 Referent
2.00–3.99 12 62 0.19 0.12, 0.32 1.42 0.73, 2.79 8 19 0.42 0.25, 0.71 4.09 1.47, 11.35
‡ 4.00 20 38 0.53 0.39, 0.71 3.08 1.76, 5.36 15 26 0.58 0.42, 0.80 4.15 1.56, 11.02
UFS, cm
< 2.00 8 62 0.13 0.07, 0.25 1.00 Referent 32 78 0.41 0.31, 0.54 1.00 Referent
2.00–3.99 22 60 0.37 0.26, 0.51 2.93 1.42, 6.02 69 140 0.49 0.42, 0.58 1.19 0.87, 1.62
‡ 4.00 22 40 0.55 0.42, 0.73 4.26 2.11, 8.60 100 127 0.79 0.72, 0.86 1.88 1.42, 2.49
RFTS, Right From The Start; UFS, Uterine Fibroid Study; Se, sensitivity of self-report; SeR, sensitivity ratio; CI, confidence interval.
aAdjusted for age and parity.
FIG. 3. Association of demographic and reproductive factors with specificity of self-reported uterine fibroid status among
1767 RFTS and 362 UFS participants with no fibroids detected at study ultrasound. Specificity ratios are specificity of self-
report in subgroup of interest compared to specificity in the reference group. UFS specificity ratios are adjusted for parity,
and (for unstratified estimates) race/ethnicity. RFTS estimates are unadjusted. aAmong women with a previous pregnancy.
bEstimates obtained using Poisson regression.
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An additional strength of this analysis is use of ultrasound
to define ‘‘true’’ fibroid status. Ultrasound has been shown to
have high sensitivity (99%) and specificity (91%) when com-
pared to the gold standard histological results.19 A potential
limitation in measuring true fibroid status is that the RFTS
population consisted of pregnant women whose fibroids may
have grown during early pregnancy, and identification of any
resulting newly detectable cases would result in lower sensi-
tivity.20 However, ultrasound was performed very early in
the first trimester, and previous analyses of RFTS data
showed no difference in fibroid prevalence by gestational age
at ultrasound,8 so detection is unlikely to be influenced within
the narrow time period in which examinations were con-
ducted. Pregnancy may also have affected the validity of the
ultrasound results, but study sonographers were specially
trained to ensure that focal contractions were not mistaken for
fibroid tumors.
Conclusions
In this analysis, between 35% and 90% of women with
ultrasound-detected fibroids reported that they had never
been diagnosed with fibroids. Previous investigations21,22
using self-reported fibroid diagnosis have limited analyses
to women under 35 years in an attempt to reduce misclas-
sification. Our findings confirm that the high specificity and
lower prevalence of fibroids among younger women would
result in relatively fewer true cases being misclassified.
However, differences in reporting quality with respect to
other factors may still lead to biased estimates. For example,
higher sensitivity among parous women results in a higher
likelihood of reporting a fibroid diagnosis. In the simplest
case (i.e., assuming no confounding, other measurement
errors, or selection bias), this would lead to parity being
an apparent risk factor for uterine fibroids. On the other
hand, if women who report a fibroid diagnosis prior to
the baseline of a prospective analysis are excluded, then
cases would be differentially excluded among parous com-
pared to nulliparous women, and parity would seem to be
protective.
Our results provide detailed information that could be used
for more accurate assessment of misclassification bias in ex-
isting studies. The availability of methods23–25 that allow for
varying sensitivity and specificity according to designated
covariate patterns provides an opportunity to calculate point
and interval estimates that account for the differential validity
of self-reported fibroid diagnosis. However, accurate out-
come measurement through ultrasound screening remains
critical to clarify the relationships between risk factors that
may be important in the onset of fibroids and those that play a
role in their growth and detection.
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